VOICED : Nueva esperanza contra malaria

The video discusses promising results from clinical trials of a new malaria vaccine, which offers up to 100% protection in adults receiving high doses. The vaccine, made from weakened live parasites, faces production challenges due to the complex extraction process and storage requirements. Despite these hurdles, the vaccine represents a significant step forward in combating malaria, a disease affecting 220 million people annually, with a high mortality rate in sub-Saharan Africa.

¿Qué proceso deben realizar los técnicos para extraer los parásitos necesarios para la vacuna?

Según la Organización Mundial de la Salud, ¿cuántas personas son infectadas anualmente por la malaria?